🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
This is a single-arm, open-label and exploratory clinical study of Anlotini...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2019-06-10
Trial ID
NCT04052152
Treatments Being Tested
To evaluate the efficacy and safety of Anlotinib Hydrochloride in Combinati...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2020-01-01
Trial ID
NCT04300959
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04813406
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Sintili...
Status
Completed
Location
NeoSACT
Start Date
2021-09-15
Trial ID
NCT04877821
Treatments Being Tested
\*\*Primary Objective:\*\* The primary objective of this study is to evalua...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07239622
Treatments Being Tested
This study was a single-arm, open-label, phase II study of PD-1 monoclonal ...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2019-08-01
Trial ID
NCT04790409
Treatments Being Tested
This study is a prospective, single-arm, multicenter, phase Ib/II clinical ...
Status
Recruiting
Location
First Affiliated Hospital of Fujian Medical University
Start Date
2024-12-23
Trial ID
NCT06761027
Treatments Being Tested
This is an open label, multi-center, randomized control phase II trial, to ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10
Trial ID
NCT04124731
Treatments Being Tested
This is a prospective single-center, open-label, phase II study evaluating ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-02-01
Trial ID
NCT06221462
Treatments Being Tested